Edition:
India

Biocon Ltd (BION.NS)

BION.NS on National Stock Exchange of India

258.15INR
16 Jul 2019
Change (% chg)

Rs5.45 (+2.16%)
Prev Close
Rs252.70
Open
Rs252.95
Day's High
Rs258.80
Day's Low
Rs250.00
Volume
2,314,557
Avg. Vol
3,408,667
52-wk High
Rs359.00
52-wk Low
Rs230.00

About

Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

RPT-ICRA ratings for Indian debt instruments-Mar 18

(Repeating to add more ratings) Mar 18 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of March 15, 2019. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: -----------------

19 Mar 2019

BUZZ-India's Biocon hits over 2-wk low; plant gets observations from U.S. FDA

** Biopharmaceutical company Biocon Ltd's shares fall as much as 3 pct to 607.05 rupees, their biggest intraday pct loss since Feb. 15

07 Mar 2019

Biocon quarterly profit more than doubles, beats estimate

Indian biotechnology firm Biocon Ltd's quarterly profit more than doubled, handily beating analysts' estimates, largely driven by strong performance of its biologics businesses.

24 Jan 2019

India's Biocon quarterly profit more than doubles, beats estimate

Jan 24 Indian biotechnology firm Biocon Ltd's quarterly profit more than doubled, handily beating analysts' estimates, largely driven by strong performance of its biologics businesses.

24 Jan 2019

Earnings vs. Estimates

No consensus analysis data available.